Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0796
    +0.0002 (+0.02%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2637
    +0.0015 (+0.12%)
     
  • USD/JPY

    151.2300
    -0.1420 (-0.09%)
     
  • Bitcoin USD

    70,106.73
    -1,150.84 (-1.62%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Former Arris Bull Grows Cautious, Lowers Stock To Equal-Weight

Despite a 15-percent decline throughout 2017, ARRIS International plc (NASDAQ: ARRS) was still favorably viewed by some on the Street, but on Tuesday a notable analyst changed their previously bullish thesis.

The Analyst

Morgan Stanley's Meta Marshall downgraded Arris' stock rating from Overweight to Equal-weight with a price target lowered from $34 to $31.

The Thesis

The bullish case for owning Arris was based on expectations for the company to show EPS leverage as the DOCSIS upgrade created an attractive business mix shift, Marshall said in a note. (See Marshall's track record here.)

But now the telecom company has shown a lack of ability to deliver upward estimate revisions, which may put a pause to any valuation growth — and this trend will likely continue for at least the next six to nine months, the analyst said.

Arris' gross margins have fallen 130 basis points in the past year due to a significant increase in DRAM pricing coupled with the company's difficulties in passing on the price increase to customers, Marshall said. The trend of increasing DRAM prices is likely to continue for at least the next six months, which implies it will be difficult for the company to avoid incremental gross margin pressures in 2018, the analyst said.

Another bullish catalyst was a favorable view of the Ruckus/ICX acquisition, but the upside from the transaction won't be seen until the second half of 2018, according to Morgan Stanley.

Price Action

Arris was trading nearly flat as of midday Tuesday.

Related Links:

30 Stocks Moving In Tuesday's Pre-Market Session

A Peek Into The Markets: U.S. Stock Futures Up Ahead Of Economic Data

Photo courtesy of Arris.

Latest Ratings for ARRS

Dec 2017

Morgan Stanley

Downgrades

Overweight

Equal-Weight

Oct 2017

Jefferies

Maintains

Buy

Jun 2017

BTIG Research

Initiates Coverage On

Buy

View More Analyst Ratings for ARRS
View the Latest Analyst Ratings

See more from Benzinga

© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement